The clinical research landscape is evolving—and ICH E6(R3) is at the forefront of that transformation. Join us for an exclusive webinar unveiling the key findings from the newly released 2025 Avoca State of the Industry Report, which focuses on the industry’s readiness and response to the upcoming ICH E6(R3) mandate.
Don’t miss this opportunity to explore how organizations are adapting, where gaps remain, and what best practices are emerging across the industry. Whether you’re leading strategy or driving operational change, this webinar will equip you with the insights you need to stay ahead.
What You’ll Learn:
- Key trends and takeaways from the 2025 Avoca Industry Report.
- How peers are approaching ICH E6(R3) implementation.
- Practical steps to assess and improve your organization’s readiness.
Who Should Watch:
Sponsor, CRO, and research site clinical operations leaders, regulatory professionals, quality and compliance teams, and anyone involved in GCP implementation and oversight.
Watch the Webinar Below:
ICH E6(R3) Readiness Assessment
To diagnose your organization’s readiness for ICH E6(R3), take our nine-question assessment and receive a custom read-out on your overall level of preparedness and areas of focus to enable successful implementation.
Moderator:
Speakers:
Michelle Webb
Vice President, Avoca Quality Consortium, Quality Solutions & Strategic Partnering, WCG
Karen Harvey
Senior Director, Avoca Quality Consortium, WCG
Successfully implement ICH E6(R3) guidance updates with support through WCG’s Avoca Quality Consortium (AQC) membership and consulting solutions.
Leverage the AQC’s ICH E6(R2)/(R3) Side-by-Side Comparison resource to support continuous quality compliance. Over 200 clinical research organizations collaborate as part of the AQC and benefit from access to 1,500+ industry tools, templates, and metrics for every stage of the clinical trial process.